Metropolis Healthcare Limited
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more
Metropolis Healthcare Limited (METROPOLIS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.091x
Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has a cash flow conversion efficiency ratio of 0.091x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹1.32 Billion) by net assets (₹14.43 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Metropolis Healthcare Limited - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Metropolis Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Metropolis Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Metropolis Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Create Technology & Science Co Ltd
SHE:000551
|
0.010x |
|
Nanjing Kangni Mechanical & Electrical Co Ltd
SHG:603111
|
0.014x |
|
Elkem ASA
OTCGREY:ELKEF
|
0.023x |
|
Young & Co.'s Brewery P.L.C.
PINK:YCSBF
|
0.029x |
|
Hunan Yussen Energy Technology
SHE:002986
|
-0.020x |
|
Sanhe Tongfei Refrigeration Co. Ltd.
SHE:300990
|
0.029x |
|
Banca Farmafactoring S.p.A.
LSE:0RON
|
0.865x |
|
Huayi Brothers Media Corp
SHE:300027
|
0.002x |
Annual Cash Flow Conversion Efficiency for Metropolis Healthcare Limited (2014–2025)
The table below shows the annual cash flow conversion efficiency of Metropolis Healthcare Limited from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹13.35 Billion | ₹2.63 Billion | 0.197x | -18.05% |
| 2024-03-31 | ₹10.99 Billion | ₹2.64 Billion | 0.240x | -3.68% |
| 2023-03-31 | ₹9.91 Billion | ₹2.47 Billion | 0.249x | -12.54% |
| 2022-03-31 | ₹8.88 Billion | ₹2.53 Billion | 0.285x | -18.92% |
| 2021-03-31 | ₹7.08 Billion | ₹2.49 Billion | 0.352x | -14.09% |
| 2020-03-31 | ₹5.25 Billion | ₹2.15 Billion | 0.409x | +90.72% |
| 2019-03-31 | ₹4.20 Billion | ₹901.51 Million | 0.215x | -11.37% |
| 2018-03-31 | ₹4.29 Billion | ₹1.04 Billion | 0.242x | -18.09% |
| 2017-03-31 | ₹3.44 Billion | ₹1.02 Billion | 0.296x | -4.95% |
| 2016-03-31 | ₹2.94 Billion | ₹914.16 Million | 0.311x | +72.03% |
| 2015-03-31 | ₹3.84 Billion | ₹694.91 Million | 0.181x | -25.29% |
| 2014-03-31 | ₹3.18 Billion | ₹769.22 Million | 0.242x | -- |